Ridaura TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: auranofin
Brand name
(ARTG)
: RIDAURA auranofin 3mg tablet bottleDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
INDICATIONS AS AT 14 NOVEMBER 2000: Adjunctive treatment of active classical or definite rheumatoid arthritis in adults who have an insufficient therapeutic response to, or are intolerant of, an adequate trial of a baseline therapeutic program, including among other measures, full doses of one or more non-steroidal anti-inflammatory drugs. RIDAURA is not indicated in non-rheumatoid arthropathies such as osteoarthrosis. RIDAURA should be added to a comprehensive baseline therapeutic program.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, film coated
- Oral
- Pale yellow square, bevel-edged, film coated tablet having raised domes on both faces.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Protect from Light
- Shelf lifetime is 4 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 15 Tablets pack
- 60 Tablets pack
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is
- 60 Tablets (E) pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient auranofin
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
